Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: Diurnal trio dip in after EMA submission in December

Mon, 16th Jan 2017 15:08

(ShareCast News) - A trio of Diurnal Group directors bought shares in the hormone disease specialist, which remain little higher than the low reached late last year.Chairman Peter Allen bought 40,000 shares at 105p and non-executive directors Sam Williams and John Goddard bought 9,248 each at a price of 108p.Diurnal, which floated on AIM in December 2015 market authorisation in late 2017, last month submitted the marketing application to the European Medicines Agency for Infacort, which has the potential to be the first licensed treatment in Europe for Adrenal Insufficiency (AI) specifically designed for use in children under six years of age.This was made on the back of "highly statistically significant" data from clinical trials, with the EMA having already approved a paediatric investigation plan (PIP) for Infacort that set out the regulatory pathway to market authorisation.Diurnal anticipates market authorisation in late 2017, with product revenues expected from early 2018 and the company estimating the total market for paediatric AI and the related condition Congenital Adrenal Hyperplasia in Europe is approximately $28m per year.Top Director BuysDiurnal Group (DNL)Director name: Allen,PeterAmount purchased: 40,000 @ 105.00pValue: £42,000.00Diurnal Group (DNL)Director name: Goddard,JohnAmount purchased: 9,248 @ 108.00pValue: £9,987.84Diurnal Group (DNL)Director name: Williams,SamAmount purchased: 9,248 @ 108.00pValue: £9,987.84Jardine Lloyd Thompson Group (JLT)Director name: Walsh,NicholasAmount purchased: 1,000 @ 997.42pValue: £9,974.25Haydale Graphene Industries (HAYD)Director name: Gibbs,Raymond (Ray) JohnAmount purchased: 4,353 @ 160.00pValue: £6,964.80Fidelity Asian Values (FAS)Director name: Stott,GrahameAmount purchased: 4,000 @ 31.00pValue: £1,240.00Vodafone Group (VOD)Director name: Schellekens,Ronald Amount purchased: 118 @ 212.45pValue: £250.69Sthree (STHR)Director name: Smith,AlexAmount purchased: 65 @ 319.00pValue: £207.35Sthree (STHR)Director name: Elden,GaryAmount purchased: 64 @ 319.00pValue: £204.16Supergroup (SGP)Director name: Sutherland ,EuanAmount purchased: 9 @ 1,712.00pValue: £154.08Supergroup (SGP)Director name: Cartwright,Andrea Amount purchased: 9 @ 1,712.00pValue: £154.08Aviva (AV.)Director name: Amin,NitinbhaiAmount purchased: 31 @ 480.80pValue: £149.05Shoe Zone (SHOE)Director name: Davis ,Nicholas (Nick)Amount purchased: 7,000 @ 1.80pValue: £126.00Top Director SellsRenew Holdings (RNWH)Director name: Samuel,JohnAmount sold: 112,518 @ 434.00pValue: £488,328.14Lindsell Train Inv Trust (LTI)Director name: Landman,RoryAmount sold: 100 @ 86,500.00pValue: £86,500.00
More News
13 Nov 2020 16:06

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
28 Oct 2020 19:08

IN BRIEF: Diurnal Taps Investors For GBP9.8 Million

IN BRIEF: Diurnal Taps Investors For GBP9.8 Million

Read more
21 Oct 2020 21:15

IN BRIEF: Diurnal's Swiss Partner Seeks Marketing Approval For Alkindi

IN BRIEF: Diurnal's Swiss Partner Seeks Marketing Approval For Alkindi

Read more
21 Oct 2020 15:40

Diurnal up as its partner advances Swiss authorisation for 'Alkindi'

(Sharecast News) - Speciality pharmaceuticals company Diurnal Group announced on Wednesday that its marketing and distribution partner in Switzerland, EffRx Pharmaceuticals, has submitted a market authorisation application to Swissmedic for the registration of 'Alkindi', or hydrocortisone granules in capsules for opening, in the country.

Read more
9 Oct 2020 16:13

Diurnal raising up to £10m in placing and open offer

(Sharecast News) - Speciality pharmaceuticals company Diurnal Group announced a proposed conditional placing with institutional investors to raise up to £8m before expenses on Friday, at a price of 60p per share, and an open offer to raise up to a further £2m.

Read more
9 Oct 2020 11:56

Diurnal Raises GBP8 Million For Product Development, Commercialisation

Diurnal Raises GBP8 Million For Product Development, Commercialisation

Read more
30 Sep 2020 14:28

IN BRIEF: Diurnal Gets US FDA Approval For Alkindi Sprinkle

IN BRIEF: Diurnal Gets US FDA Approval For Alkindi Sprinkle

Read more
15 Sep 2020 16:01

IN BRIEF: Diurnal Annual Revenue Climbs And Loss Narrows

IN BRIEF: Diurnal Annual Revenue Climbs And Loss Narrows

Read more
14 Sep 2020 13:13

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

Read more
8 Sep 2020 16:02

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
3 Sep 2020 14:04

IN BRIEF: Diurnal Inks Two European Marketing And Distribution Pacts

IN BRIEF: Diurnal Inks Two European Marketing And Distribution Pacts

Read more
3 Sep 2020 11:35

Diurnal signs two new distribution agreements in Europe

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced two further European market and distribution agreements for its products 'Alkindi', or hydrocortisone granules in capsules for opening, and 'Chronocort', or modified release hydrocortisone, on Thursday.

Read more
10 Aug 2020 11:10

IN BRIEF: Australian Regulator Approves Diurnal Drug Alkindi

IN BRIEF: Australian Regulator Approves Diurnal Drug Alkindi

Read more
5 Aug 2020 19:16

UK TRADING UPDATE SUMMARY: Regional REIT Valuation Dips In First Half

UK TRADING UPDATE SUMMARY: Regional REIT Valuation Dips In First Half

Read more
26 May 2020 17:50

Clinigen Chair Leaves Audit Committee After Shareholder Engagement

Clinigen Chair Leaves Audit Committee After Shareholder Engagement

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.